Over 3,500 people with HIV are on waiting lists for lifesaving antiretroviral drugs. Many more lack access because of other funding cuts and program restrictions. Congress and President Barack Obama must act now to make sure all persons with HIV…
By Mark Harrington On September 30, 2010 the U.S. National Institutes of Health (NIH) became the first research funder to license intellectual property rights to the Medicines Patent Pool essential to manufacturing anti-HIV protease inhibitors. The patent pool is an…
By Coco Jervis and Sue Perez Over the last few years, G8 and other national leaders have lamented that health care systems in poor countries are inadequate to keep pregnant women, mothers, babies, and children healthy and that universal access…
By Richard Jefferys and Scott Morgan In July of this year, the stubborn persistence and commitment of microbicide researchers, advocates, and trial participants was finally rewarded with positive results from a South African trial of the gel form of the…
Slow Implementation for Needed Changes By Sue Perez and Coco Jervis After a century of failed efforts, decades of debate, and months of partisan rancor, this past March, Congress finally passed the Patient Protection and Affordable Care Act of 2010…
By Scott Morgan With no end to the global funding retreat in sight, new strategies are required to change the way we provide treatment to the world's 33 million people infected with HIV. On June 7-10, the Clinton Health Access…